More compact doses for perioral treatment than for upper facial programs are employed because the oral musculature responds much more strongly to the same BTX-A dosing. Just one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA acceptance lies in treatments of cervical dystonia. Following https://karelz812cwp9.blogrenanda.com/profile